Unveiling the Invisible Impact: Exploring Musculoskeletal Symptoms in Healthcare Students Post COVID-19 Infection. A Cross-Sectional Study in Jordan
DOI:
https://doi.org/10.35516/jmj.v59i2.2326Keywords:
COVID-19, Long-COVID, Musculoskeletal Symptoms, Post-acute COVID-19 Syndrome, Young patientsAbstract
Background and Aims: Recent studies found a lot of COVID-19 patients reporting persistent musculoskeletal symptoms after recovering from the acute infection. This study assessed musculoskeletal symptoms in young individuals in Jordan three months after mild to moderate COVID-19 infection, examining the impact of gender and other factors due to a lack of regional research on post-acute COVID-19 complications.
Materials and Methods
Methods: We conducted a cross-sectional study from November 2022 to December 2022, using an online questionnaire on Google Forms distributed to university healthcare students via social media. The questionnaire assessed demographics, COVID-19 symptoms including musculoskeletal symptoms, and their association with patient characteristics and disease course.
Results: 261 students, comprising 177 (67.8%) females and 84 (32.2%) males with a mean age of 21.41, participated in our research. 21.4% of our participants complained of at least one musculoskeletal symptom after the acute phase of COVID-19 infection, among which fatigue was the most common (71.6%) followed by headache (60.9%) and muscle pain (52.5%). Female gender was found to be significantly associated with a higher risk of developing musculoskeletal symptoms after the acute phase of COVID-19 infection.
Conclusion: The current study found that many young people who recovered from COVID-19 continue to experience musculoskeletal complaints, which could impact their daily activities and contribute to the burden of the disease. There is a higher prevalence of back pain and joint pain complaints in females, which requires further investigation. Cohort studies may help to better understand the relationship between COVID-19 and ongoing musculoskeletal problems.
References
Tuzun S, Keles A, Okutan D, Yildiran T, Palamar D. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur J Phys Rehabil Med. 2021 Aug; 57(4): 653-662.
(n.d.). https: //covid19.who.int/
Janbazi L, Kazemian A, Mansouri K, Madani SP, Yousefi N, Vahedifard F, et al. The incidence and characteristics of chronic pain and fatigue after 12 months later admitting with COVID-19; The Post- COVID 19 syndrome. Am J Phys Med Rehabil. 2022 Apr 13. doi: 10.1097/PHM.0000000000002030.
Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and Myositis: What We Know So Far. Curr Rheumatol Rep. 2021 Jul 3; 23(8): 63.
Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, et al. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020 Jul 15; 102(14): 1197-1204.
Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int J Environ Res Public Health. 2021 Mar 5; 18(5): 2621.
Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne). 2021 May 4; 8: 653516.
Moran EM, Mastaglia FL. Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications. Clin Exp Immunol. 2014 Dec; 178(3): 405-15.
Cipollaro L, Giordano L, Padulo J, Oliva F, Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J Orthop Surg Res. 2020 May 18; 15(1): 178.
Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020 Nov; 132(8): 749-755.
Azadvari M, Haghparast A, Nakhostin-Ansari A, Emami Razavi SZ, Hosseini M. Musculoskeletal symptoms in patients with long COVID: A cross-sectional study on Iranian patients. Heliyon. 2022 Aug; 8(8): e10148.
Bliddal S, Banasik K, Pedersen OB, Nissen J, Cantwell L, Schwinn M, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021 Jun 23; 11(1): 13153. 13. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020 Aug 11; 324(6): 603-605.
Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021 Jul; 27(7): 1041.e1-1041.e4.
Karaarslan F, Güneri FD, Kardeş S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. 2022 Jan; 41(1): 289-296.
Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021 Apr; 76(4): 405-407.
Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020 Jul 31; 69(30): 993-998.
Varghese J, Sandmann S, Ochs K, Schrempf IM, Frömmel C, Dugas M, et al. Persistent symptomsand lab abnormalities in patients who recovered from COVID-19. Sci Rep. 2021 Jun 17; 11(1): 12775.
Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021 Oct; 53(10): 737-754.
Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mulè G, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022 Apr; 28(4): 611.e9-611.e16.
Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SKJB, Islam MS, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021 Apr 8; 16(4): e0249644.
Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021 Oct; 27(10): 1507-1513.
Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y. Sex-based differences in autoimmune diseases. Ann Ist Super Sanita. 2016 Apr-Jun; 52(2): 205-12.
Soetanto AL, Chung JW, Wong TK. Are there gender differences in pain perception? J Neurosci Nurs. 2006 Jun; 38(3): 172-6.
